Company Filing History:
5 out of 5 
4 out of 4 
3 out of 3 
Years Active: 2008-2025
Title: The Innovative Contributions of Christophe Lallemand
Introduction
Christophe Lallemand is a prominent inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the development of cell-based assays. With a total of nine patents to his name, Lallemand's work has advanced the methodologies used in immuno-assay platforms.
Latest Patents
One of Lallemand's latest patents is focused on secreted reporter-peptides for optimizing cell-based assays for analysis on immuno-assay platforms. This invention involves small secreted reporter-peptides that are functionally linked to response elements activated by pharmacologically active substances. The innovation allows for simultaneous analysis of multiple analytes and improves the dynamic range and sensitivity of cell-based assays. Another notable patent relates to the quantification of antibody-dependent cell-mediated cytotoxicity (ADCC) and phagocytosis (ADCP) using novel cells and methods.
Career Highlights
Throughout his career, Christophe Lallemand has worked with various organizations, including Biomonitor Limited and the Centre National de la Recherche Scientifique. His expertise in biotechnology has positioned him as a key figure in the development of innovative solutions for complex biological analyses.
Collaborations
Lallemand has collaborated with notable professionals in his field, including Michael Gerard Tovey and Benoit Vallette. These collaborations have further enriched his research and contributed to the advancement of his inventions.
Conclusion
Christophe Lallemand's contributions to biotechnology through his patents and collaborations have significantly impacted the field of immuno-assays. His innovative approaches continue to enhance the efficiency and effectiveness of cell-based assays.